1. Introduction {#sec1}
===============

Long dan Xie gan pill is prepared from ten species of crude drugs including *Gentianae radix* et rhizoma, *Scutellariae radix*, and *Akebiae caulis* (Mutong) in Chinese Pharmacopoeia (2015 Edition, Volume I) \[[@B1]\]. It is widely used for the treatment of diseases, including hepatocolic hygropyrexia, dizziness, tinnitus and deafness, hypochondriac pain \[[@B1]\]. The preparation has attracted widespread attention, since it caused aristolochic acid nephropathy (AAN) \[[@B2], [@B3]\]. At that time, the prescription collected the crude drug of Caulis aristolochiae manshuriensis (Guanmutong) instead of *Akebiae caulis* \[[@B4]--[@B6]\]. Because of the serious adverse effect of aristolochic acids, the medicinal standard of Caulis aristolochiae manshuriensis was abolished and replaced by *Akebiae caulis* without containing such toxic constituents since 2003.

As one commonly used Chinese patent medicine (CPM) with a long history, Long dan Xie gan pill has about 200 manufacturers. Therefore, the quality of products from different manufacturers may be varied. Since quality is directly related to drug safety and efficacy, it is very important to evaluate the holistic quality of the products. Researchers have been working on the essential quality control and evaluation methods for years \[[@B2]\]. For most CPMs, the effective components are not clear and the consistency of product quality is a key indicator of quality product evaluation. It is worth mentioning that fingerprint is an internationally recognized effective method because it could reflect the overall quality information \[[@B2]--[@B10]\]. However, fingerprint is usually used for qualitative consistency evaluation. And the quantification could be achieved by applying multicomponent determination \[[@B10]--[@B13]\]. In recent years, more and more chromatographic and spectroscopic methods including LC, LC-MS^n^, and quantitative nuclear magnetic resonance (QNMR) are applied for the aforementioned qualitative and quantitative work \[[@B14]--[@B21]\]. Among these methods, high-performance liquid chromatography (HPLC) is still the main method deployed in quality control of traditional Chinese medicines (TCMs) because of its advantages, including good repeatability, wide application, and high efficiency.

In this study, the qualitative and quantitative consistency information of Long dan Xie gan pill samples was achieved at the same time by a combination of fingerprint with multicomponent quantification by HPLC-diode array detector (DAD) with dual channels (UV 240 nm and 285 nm). Additionally, further deep mining of the data by chemometrics analysis helped to evaluate the differences of products in a more comprehensive and effective way. The results indicated that the established method could comprehensively analyze the product quality. This strategy could provide a practical approach for the holistic quality control of TCM.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Reagents {#sec2.1}
---------------------------

Gentiopicrin (97.6%, batch no. 110770-201716), baicalin (93.5%, batch no. 110715-201720), baicalein (98.5%, batch no. 111595-201607), and wogonin (100%, batch no. 111514-201605) were from the National Institutes for Food and Drug Control, Beijing, China. Methanol (analytical reagent) was from National Drug Chemical Reagents Co. Ltd. Acetonitrile (chromatographic pure) and formic acid (mass spectrometry reagent) were from Thermo Fischer Scientific. The water was of ultrahigh purity.

2.2. Materials {#sec2.2}
--------------

Fifty batches of Long dan Xie gan pill samples were from 8 manufacturers (A∼H). All the samples involve two dosage forms including water-bindered pills (WBP) and big candied pills (BCP). The detailed information is listed as follows ([Table 1](#tab1){ref-type="table"}).

2.3. Instrumentations {#sec2.3}
---------------------

HPLC analysis was performed on a Waters 2690 HPLC instrument (Waters, Milford, USA), equipped with a DAD, an autosampler and a column heater. METTLER XS105 electronic analytical balance (Mettler-toledo, Zurich, Switzerland), Milli-Q water purification system (Milli-pore, Burlington, USA), and KQ-300DA numerical control ultrasound cleaning instrument (Kunshan Ultrasonic Instruments Co. Ltd., Kunshan, China) were used. Chemometrics analysis was achieved by ChemPattern software (Chenmind Technologies Co., Ltd., Beijing, China).

2.4. Preparation of Standard Solutions {#sec2.4}
--------------------------------------

Standard stock solutions of baicalin (0.1 mg·mL^−1^) were prepared by dissolving suitable amounts of reference substance in methanol for fingerprint establishment.

Standard stock mixed solution of gentiopicrin (0.4972 mg·mL^−1^), baicalin (0.5268 mg·mL^−1^), baicalein (0.4688 mg·mL^−1^), and wogonin (0.5080 mg·mL^−1^) was prepared by dissolving suitable amounts of each reference substance in methanol for multicomponents assay.

2.5. Preparation of Sample Solutions {#sec2.5}
------------------------------------

For Long dan Xie gan pill (WBP) (6 g per small bag), 5 bags were mixed and pulverized to powder. For Long dan Xie gan pill (BCP) (6 g per pill), 5 pills were cut into small pieces. Then, 2 g were weighed accurately and put into a 50 mL plug conical bottle. Twenty-five mL methanol (for WBP samples) and 25 mL 80% methanol-water solution (for BCP samples) were added precisely and weighed, respectively. After extracting by ultrasonication (power: 300 W; frequency: 40 kHz) for 30 min, the extract was cooled down and then made up for lost weight by adding methanol (for WBP samples) or 80% methanol (for BCP samples). The continuous filtrate was taken and then filtered by 0.22 *μ*m microporous filter membrane.

2.6. HPLC-DAD Chromatographic Condition {#sec2.6}
---------------------------------------

Column: Phenomenex Gemini C18 (4.60 × 250 mm, 5 *μ*m); mobile phase: gradient elution with acetonitrile- (A-)0.1% formic acid-water solution (B) (0--5 min, 7%A--10%A; 5--11 min, 10%A--15%A; 11--15 min, 15%A--20%A; 15--32 min, 20%A--30%A; 32--54 min, 30%A--55%A; 54--60 min, 55%A--80%A; and 60--68 min, 7%A); flow rate: 1.0 mL·min^−1^; column temperature: 30°C; injection volume: 10 *µ*L; detection wavelength: UV 240 nm for fingerprint and UV 285 nm for multicomponent determination. The typical chromatograms were shown as Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, respectively.

2.7. Mass Spectrometry Condition {#sec2.7}
--------------------------------

MS analysis was performed on an Agilent1260-6410B LC-MS couplet system equipped with Agilent Mass Hunter ChemStation (Agilent, Santa Clara, USA). The mass spectrometry settings were as follows: split ratio = 1 : 9; desolvation temperature: 350°C; desolvation air flow N~2~: 540 L·h^−1^; nebulizer pressure: 30 psi; and capillary: 4000 V. Both positive and negative modes were performed with a scan range of *m*/*z* 50--1200.

3. Results and Discussion {#sec3}
=========================

3.1. Results of Fingerprint {#sec3.1}
---------------------------

For fingerprint study, all the samples were prepared and analyzed according to conditions under 2.5 and 2.6. Baicalin (*t*~R~ = 34.02 min) was taken as the reference peak. Relative retention times (RRTs) and relative peak areas (RPAs) of the characteristic peaks were calculated for method validation.

### 3.1.1. Instrument Precision {#sec3.1.1}

The same sample solution (no. 21) was injected for six consecutive times. The result showed that the RSDs of RRTs and RPAs were in the range of 0.073%--2.0% and 0.26--1.74%, respectively. It showed that the precision of the instrument was good.

### 3.1.2. Repeatability {#sec3.1.2}

The same batch sample (no. 21) was taken and prepared for six independent sample solutions for analysis. The result showed that the RSDs of RRT and RPA were in the range of 0.010%--0.44% and 0.51--2.24%, respectively. It indicated that method repeatability was good.

### 3.1.3. Stability {#sec3.1.3}

The same sample solution (no. 21) was injected at 0, 4, 8, 12, 16, 20, and 24 h at room temperature. The result showed that the RSDs of RRT and RPA were in the range of 0.039%--0.81% and 0.71--4.58%, respectively. It demonstrated the sample solution was stable within 24 h.

### 3.1.4. Establishment of Fingerprint {#sec3.1.4}

After fifty batches of the sample solutions were analyzed, their chromatograms (UV 240 nm) were recorded ([Figure 3](#fig3){ref-type="fig"}) and imported to ChemPattern software. All variables were used as the common peak screening condition. And Gauss curve simulation method was applied to generate the common mode with 16 characteristic peaks ([Figure 4](#fig4){ref-type="fig"}). All sample chromatograms were analyzed by comparison with the common mode.

### 3.1.5. Identification and Attribution of Characteristic Peaks {#sec3.1.5}

The sample solution was analyzed according to the conditions under Sections [2.6](#sec2.6){ref-type="sec"} and [2.7](#sec2.7){ref-type="sec"}. By combination with the chromatographic behavior of the components, ten characteristic peaks were identified by comparing with reference standards. Also the main origins of the peaks were attributed ([Table 2](#tab2){ref-type="table"}), and they were mainly from five species of crude drugs in the prescription.

### 3.1.6. Statistical Analysis {#sec3.1.6}

*(1) Similarity Analysis*. The above HPLC (UV 240 nm) fingerprint common mode was taken as a reference. During the analysis, the included angle cosine method was used to calculate the similarity of each sample ([Figure 5](#fig5){ref-type="fig"}). Finally, the similarities of all samples were in the range of 0.65∼0.99. Among them, similarities of seven batches of samples were lower than 0.8, including all samples from enterprise B. The result indicated that there was a certain difference among the overall product quality of these samples from others. Also it was clear that the uniformity of most BCP samples (no. 6∼10 and 26∼30) was not good as the WBP ones.

*(2) Principle Component Analysis*. Principle component analysis (PCA) was carried out after standardization of all sample data (Figures [6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). The contribution rates of the first and second principle component (PC1) were 45.92% and 39.22%, respectively. And the total contribution rate of 85.14% showed that it could reflect the differences between samples in a more comprehensive way. PCA scatter plot ([Figure 6](#fig6){ref-type="fig"}) displayed that samples from each enterprise basically could be grouped into a class. It showed that samples from enterprise B deviated far away from others. The principle component load diagram ([Figure 7](#fig7){ref-type="fig"}) gave the proportion of each chromatographic peak in the principal component. And the greater the distance from *X* = 0 longitudinal axis, the greater the contribution to PC1, such as gentiopicrin and baicalein. Likewise, the greater the distance from *Y* = 0 transverse axis, the greater the contribution to PC2, such as baicalein and geniposide. The result displayed that samples from enterprise B separated with others along both PC1 and PC2. Therefore, the major contributions to PC1 and PC2 were their main differential components from others. Because of the location at the position of PC1 \> 0 and PC2 \< 0, contents of such compounds were in positive correlation with PC1 and in negative correlation with PC2. Therefore, the contents of baicalein and wogonin were higher in these samples. Along the PC1, the concentration of baicalein distinguished the samples of enterprise B, whose values were higher than those presented for the others ([Figure 6](#fig6){ref-type="fig"}). On the contrary, along with the PC2, the levels of geniposide and gentiopicrin showed that there was a tendency for the separation of the products of enterprises D and G from others. One sample of enterprise A was grouped with samples of enterprises D and G, which presented higher levels for these compounds.

*(3) Cluster Analysis*. Hierarchical cluster analysis (HCA) is a conventional cluster analysis method. It is a detection tool that clearly reveals the natural grouping of data. The block distance was selected for distance calculation and HCA ([Figure 8](#fig8){ref-type="fig"}) was performed by error square sum method. Similar to the result of PCA, except that some samples from manufacturer D are not distinguished from those of A, other samples from different enterprises could basically distinguish. Additionally, samples from B were relatively most far away from others. It indicated there existed some differences of these samples.

3.2. Results of Multicomponent Quantification {#sec3.2}
---------------------------------------------

### 3.2.1. Linearity, LOD, and LOQ {#sec3.2.1}

Working standard solutions containing gentiopicrin, baicalin, baicalein, and wogonin were prepared by diluting the stock mixed solution with methanol to a series of proper concentrations. Then, they were injected and analyzed. The results of regression equations, linearity, determination coefficient, and limits of detection and quantification of the method are presented in [Table 3](#tab3){ref-type="table"}. The linear range varied from 3.25 to 492.56 *μ*g mL^−1^, in accordance with the analyte. All analytes presented a determination coefficient (*R*^2^) of the 0.9999, which allows the method to be considered linear. The limits of detection (LOD) and quantification (LOQ) were calculated according to guidelines for validation of analytical methods for pharmaceutical quality standards \[[@B22]\].

### 3.2.2. Instrument Precision {#sec3.2.2}

The same sample solution (no. 21) was injected for six consecutive times and analyzed. The RSDs of peak areas for gentiopicrin, baicalin, baicalein, and wogonin were 0.63%, 0.29%, 0.41%, and 0.15%, respectively. It indicated that the precision of the instrument was in accordance with the requirement in guidelines for validation of analytical methods for pharmaceutical quality standards \[[@B22]\].

### 3.2.3. Repeatability {#sec3.2.3}

The same batch of sample (no. 21) was taken and prepared for six independent sample solutions. Then, they were analyzed according to conditions under 2.6. The average contents of gentiopicrin, baicalin, baicalein, and wogonin were 4.77, 3.84, 0.62, and 0.40 mg·g^−1^, respectively. And the RSDs were 0.49%, 1.11%, 0.40%, and 0.56%, respectively. It indicated that method repeatability was in accordance with the requirement in guidelines for validation of analytical methods for pharmaceutical quality standards \[[@B22]\].

### 3.2.4. Stability {#sec3.2.4}

The same sample solution (no. 21) was injected at 0, 4, 8, 12, 18, and 24 h at room temperature. The RSDs of contents for gentiopicrin, baicalin, baicalein, and wogonin were 1.88%, 1.54%, 1.70%, and 3.22%, respectively. It indicated that the sample solution was stable within 24 h.

### 3.2.5. Recovery {#sec3.2.5}

The recovery experiment was performed by adding a known amount of individual reference standards into a certain amount of sample (no. 21).

Six separate samples of 1 g (contents of gentiopicrin, baicalin, baicalein, and wogonin were 4.77, 3.84, 0.62, and 0.40 mg·g^−1^, respectively) were weighed accurately. And 25 mL of mixed reference standard solution (concentrations of gentiopicrin, baicalin, baicalein, and wogonin were 0.1861, 0.1505, 0.04856, and 0.0300 mg·mL^−1^, respectively) was added separately and prepared. The results ([Table 4](#tab4){ref-type="table"}) showed that the average recoveries of four components ranged from 97.71% to 100.59% with RSDs in the range of 0.72%--1.29%, which indicated that the method was accurate.

### 3.2.6. Sample Analysis {#sec3.2.6}

Fifty batches of sample solutions were prepared and analyzed. The results ([Table 5](#tab5){ref-type="table"}) displayed that the contents of gentiopicrin, baicalin, baicalein, and wogonin were in the range of 0.61--5.40, 1.96--5.33, 0.10--3.40, and 0.046--1.16 mg·g^−1^, respectively. It was easily to find the differences among samples from different enterprises by the scatter diagram ([Figure 9](#fig9){ref-type="fig"}). It showed that the general content trends of baicalin, baicalein, and wogonin were basically similar. Among them, the contents of baicalein and wogonin in samples from B were apparently higher than others; especially, the content of baicalein was much higher. The determination result was in accordance with the abovementioned PCA analysis result.

3.3. Optimization of Experimental Conditions {#sec3.3}
--------------------------------------------

### 3.3.1. Investigation of Extraction Methods {#sec3.3.1}

The extraction method was optimized in order to make the fingerprint reflect the chemical composition information as much as possible. For both dosage forms of samples, different extraction solvent (80% methanol and 50% methanol-water), and extraction mode and time (ultrasonic extraction for 30 min, 45 min, and 60 min) were investigated. The result showed that extraction time had little effect on both dosage forms. For WBP samples, the chromatogram could reflect rich chemical information with good separation of peaks with methanol extraction for 30 min. While for BCP samples, the dissolution was good by extraction with 80% methanol-water for 30 min.

### 3.3.2. Study on the Chromatographic Condition {#sec3.3.2}

During the study, different mobile phase systems including methanol-water, acetonitrile-water, methanol-0.1% formic acid, and acetonitrile-0.1% formic acid were investigated. Also different chromatographic, columns including Waters Symmetry Shield™ RP 18, Agilent Zorbax SB-C18, and Phenomenex Gemini C18 were experimented. Additionally, both DAD and DAD-ELSD detection were analyzed. As a result, the chromatogram was good on the Phenomenex Gemini C18 column with acetonitrile-0.1% formic acid as the mobile phase under DAD detection. Finally, UV 240 nm was selected as detection wavelength for fingerprint establishment, since it could reflect much chemical information. Meanwhile, UV 285 nm was determined as detection wavelength for simultaneous determination of main compounds due to the good separation.

4. Conclusions {#sec4}
==============

Quality control is the key issue in modernization and internationalization of TCM. Qualitative fingerprint and quantitative multicomponent determination have been demonstrated as the comprehensive and effective way to accomplish the holistic quality analysis. In this study, both qualitative and quantitative works to get the overall composition and main components information were accomplished simultaneously by HPLC with dual-channel detection. Moreover, further deep mining of the data by chemometrics analysis helped to evaluate the quality of the preparation from different manufacturers. The result indicated that this approach is a powerful tool for quality control of TCM.
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![HPLC (UV 240 nm) chromatogram of the typical sample.](JAMC2018-4105092.001){#fig1}

![HPLC (UV 285 nm) chromatograms of mixed standard solution (a) (A, Gentiopicrin; B, Baicalin; C, Baicalein; and D, Wogonin) and typical sample (b).](JAMC2018-4105092.002){#fig2}

![HPLC chromatograms (UV240 nm) of Long dan Xie gan pill samples.](JAMC2018-4105092.003){#fig3}

![HPLC (UV240 nm) common mode of Long dan Xie gan pill samples.](JAMC2018-4105092.004){#fig4}

![Similarity analysis results of Long dan Xie gan pill samples.](JAMC2018-4105092.005){#fig5}

![PCA score scatter plot of Long dan Xie gan pill samples.](JAMC2018-4105092.006){#fig6}

![PCA loading scatter plot of Long dan Xie gan pill samples (1--16 represents the number of chromatographic peaks in the common mode).](JAMC2018-4105092.007){#fig7}

![Dendrograms of hierarchical cluster analysis of Long dan Xie gan pill samples.](JAMC2018-4105092.008){#fig8}

![The scatter diagram of four components\' contents in Long dan Xie gan pill samples.](JAMC2018-4105092.009){#fig9}

###### 

Sample information.

  No.   Manufacturers   Batch number   Dosage
  ----- --------------- -------------- --------
  1     A               B16099         WBP
  2     B17001                         
  3     B17045                         
  4     B16033                         
  5     B16040                         
  6     A17057          BCP            
  7     A16065                         
  8     A16119                         
  9     A17004                         
  10    A17104                         
                                       
  11    B               20170502       WBP
  12    20170504                       
  13    20170503                       
  14    171002                         
  15    171003                         
                                       
  16    C               1704058        WBP
  17    1801024                        
  18    1801027                        
  19    1801026                        
  20    1711016                        
                                       
  21    D               20180336       WBP
  22    20180335                       
  23    20180334                       
  24    20180452                       
  25    20180451                       
  26    20170621        BCP            
  27    20180419                       
  28    20170620                       
  29    20170504                       
  30    20170308                       
                                       
  31    E               180203         WBP
  32    180201                         
  33    180204                         
  34    180205                         
  35    180202                         
                                       
  36    F               171102         WBP
  37    171002                         
  38    170902                         
  39    171101                         
  40    171001                         
                                       
  41    G               1801001        WBP
  42    1802005                        
  43    1801003                        
  44    1801004                        
  45    1802006                        
                                       
  46    H               180102         BCP
  47    180101                         
  48    171001                         
  49    171002                         
  50    160501                         

###### 

Identification of characteristic peaks of Long dan Xie gan pill.

  Peak no.   Compounds              *t* ~R~ (min)   Molecular formula   Molecular weight   Quasimolecular ions   Origin
  ---------- ---------------------- --------------- ------------------- ------------------ --------------------- ------------------------------------
  3          Geniposidic acid       7.83            C~16~H~22~O~10~     374.34             372.9 \[M-H\]^−^      *Gardeniae fructus*
  6          Geniposide             15.07           C~17~H~24~O~10~     388.37             433.0 \[M+HCOO\]^−^   *Gardeniae fructus*
  7          Gentiopicrin           16.18           C~16~H~20~O~9~      356.32             400.9 \[M+HCOO\]^−^   *Gentianae radix* et rhizoma
  8          Verbascoside           22.86           C~29~H~36~O~15~     624.59             623.0 \[M-H\]^−^      Plantaginis semen/rehmanniae radix
  10         Baicalin               33.88           C~21~H~18~O~11~     446.36             445.0 \[M-H\]^−^      *Scutellariae radix*
  11         Isomer of wogonoside   38.62           C~22~H~20~O~11~     460.39             459.0 \[M-H\]^−^      *Scutellariae radix*
  12         Wogonoside             40.44           C~22~H~20~O~11~     460.39             459.0 \[M-H\]^−^      *Scutellariae radix*
  14         Baicalein              43.82           C~15~H~10~O~5~      270.24             268.9 \[M-H\]^−^      *Scutellariae radix*
  15         Isomer of wogonin      51.40           C~16~H~12~O~5~      284.26             282.9 \[M-H\]^−^      *Scutellariae radix*
  16         Wogonin                51.99           C~16~H~12~O~5~      284.26             282.9 \[M-H\]^−^      *Scutellariae radix*

###### 

Regression equations, linearity, determination coefficient, and limits of detection and quantification of the method.

  Components     Regression equations       Linear range (*μ*g·mL^−1^)   *R* ^2^   LOD (ng)   LOQ (ng)
  -------------- -------------------------- ---------------------------- --------- ---------- ----------
  Gentiopicrin   *y* = 11524 *x* + 12562    7.76∼485.27                  0.9999    0.837      2.790
  Baicalin       *y* = 32266 *x* + 4256.2   7.88∼492.56                  0.9999    0.431      1.077
  Baicalein      *y* = 43732 *x* − 23130    7.39∼461.77                  0.9999    0.439      1.025
  Wogonin        *y* = 47996 *x* + 23628    3.25∼203.20                  0.9999    0.190      0.474

###### 

Recovery results of four components in Long dan Xie gan pill samples.

  Components     No.      Sampling amount (g)   Sample content (mg)   Added amount (mg)   Detected amount (mg)   Recovery (%)   Average recovery (%)
  -------------- -------- --------------------- --------------------- ------------------- ---------------------- -------------- ----------------------
  Gentiopicrin   1        1.0005                4.772                 4.653               9.371                  98.83          100.59% (RSD 1.22%)
  2              1.0017   4.778                 4.653                 9.432               100.02                                
  3              1.0006   4.773                 4.653                 9.431               100.11                                
  4              1.0047   4.792                 4.653                 9.473               100.60                                
  5              1.0030   4.784                 4.653                 9.528               101.96                                
  6              1.0026   4.782                 4.653                 9.529               102.02                                
                                                                                                                                
  Baicalin       1        1.0005                3.842                 3.762               7.478                  96.65          97.96% (RSD 0.87%)
  2              1.0017   3.847                 3.762                 7.537               98.09                                 
  3              1.0006   3.842                 3.762                 7.503               97.32                                 
  4              1.0047   3.858                 3.762                 7.583               99.02                                 
  5              1.0030   3.852                 3.762                 7.543               98.11                                 
  6              1.0026   3.850                 3.762                 7.554               98.56                                 
                                                                                                                                
  Baicalein      1        1.0005                0.620                 1.214               1.807                  97.78          97.71% (RSD 0.72%)
  2              1.0017   0.621                 1.214                 1.802               97.28                                 
  3              1.0006   0.620                 1.214                 1.793               96.62                                 
  4              1.0047   0.623                 1.214                 1.809               97.69                                 
  5              1.0030   0.622                 1.214                 1.816               98.35                                 
  6              1.0026   0.622                 1.214                 1.818               98.52                                 
                                                                                                                                
  Wogonin        1        1.0005                0.400                 0.750               1.141                  98.80          99.98% (RSD 1.29%)
  2              1.0017   0.401                 0.750                 1.146               99.33                                 
  3              1.0006   0.400                 0.750                 1.141               98.80                                 
  4              1.0047   0.402                 0.750                 1.153               100.13                                
  5              1.0030   0.401                 0.750                 1.156               100.67                                
  6              1.0026   0.401                 0.750                 1.167               102.13                                

###### 

Contents of four components in Long dan Xie gan pills (mg·g^−1^).

  No.   Manufacturers (dosage)   Gentiopicrin   Baicalin   Baicalein   Wogonin
  ----- ------------------------ -------------- ---------- ----------- ---------
  1     A (WBP)                  1.579          3.191      0.778       0.433
  2     1.391                    2.912          0.992      0.449       
  3     3.295                    3.102          0.741      0.429       
  4     1.801                    2.582          0.718      0.381       
  5     1.884                    3.006          0.976      0.526       
                                                                       
  6     A (BCP)                  1.510          2.133      0.330       0.198
  7     0.979                    2.173          0.298      0.130       
  8     0.816                    2.269          0.337      0.176       
  9     0.746                    2.148          0.176      0.103       
  10    1.777                    2.409          0.362      0.176       
                                                                       
  11    B (WBP)                  1.019          4.153      3.049       1.129
  12    1.013                    4.394          3.141      1.158       
  13    0.963                    3.763          3.280      1.080       
  14    0.860                    4.396          3.133      0.994       
  15    0.826                    5.330          3.405      1.084       
                                                                       
  16    C (WBP)                  2.801          3.460      0.295       0.232
  17    2.442                    3.359          0.502      0.300       
  18    2.138                    3.353          0.423      0.274       
  19    2.822                    3.363          0.411      0.270       
  20    2.724                    3.889          0.294      0.216       
                                                                       
  21    D (WBP)                  4.753          3.747      0.622       0.406
  22    4.166                    3.123          0.570      0.367       
  23    4.344                    3.118          0.590      0.381       
  24    4.028                    3.047          0.585      0.385       
  25    4.084                    3.642          0.589      0.390       
                                                                       
  26    D (BCP)                  1.562          2.412      0.203       0.110
  27    1.157                    2.371          0.235      0.125       
  28    1.688                    2.337          0.189      0.102       
  29    0.606                    2.879          0.100      0.046       
  30    0.670                    3.170          0.111      0.052       
                                                                       
  31    E (WBP)                  1.922          2.210      0.722       0.314
  32    1.620                    2.205          0.698      0.324       
  33    1.815                    2.304          0.715      0.323       
  34    1.749                    2.188          0.715      0.320       
  35    1.650                    2.407          0.779      0.333       
                                                                       
  36    F (WBP)                  0.690          2.297      0.817       0.387
  37    0.669                    2.279          0.837      0.397       
  38    0.675                    2.175          0.811      0.385       
  39    0.640                    2.051          0.800      0.374       
  40    0.660                    1.963          0.821      0.394       
                                                                       
  41    G (WBP)                  4.544          4.012      0.587       0.291
  42    5.331                    3.771          0.524      0.256       
  43    5.103                    3.419          0.505      0.263       
  44    5.402                    3.990          0.567      0.261       
  45    5.128                    3.862          0.501      0.249       
                                                                       
  46    H (BCP)                  2.822          3.082      0.372       0.176
  47    2.768                    3.214          0.376      0.181       
  48    2.721                    3.177          0.367      0.178       
  49    2.736                    3.177          0.365      0.180       
  50    2.758                    3.153          0.359      0.168       

[^1]: Academic Editor: Ricardo Jorgensen Cassella
